Is CbdMD Stock a Good Investment?

CbdMD Investment Advice

YCBD

To provide specific investment advice or recommendations on cbdMD Inc stock, we recommend investors consider the following general factors when evaluating cbdMD Inc. This will help you to make an informed decision on whether to include CbdMD in one of your diversified portfolios:

Examine CbdMD's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research CbdMD's leadership team and their track record. Good management can help CbdMD navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact CbdMD's business and its evolving consumer preferences.
Compare CbdMD's performance and market position to its competitors. Analyze how CbdMD is positioned in terms of product offerings, innovation, and market share.
Check if CbdMD pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about CbdMD's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in cbdMD Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if cbdMD Inc is a good investment.

Sell

Buy

Strong Sell

We provide trade advice to complement the prevailing expert consensus on cbdMD Inc. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure CbdMD is not overpriced, please confirm all cbdMD Inc fundamentals, including its shares owned by institutions, gross profit, debt to equity, as well as the relationship between the price to book and cash and equivalents . As cbdMD Inc appears to be a penny stock we also recommend to validate its number of shares shorted numbers.

Market Performance	Weak	Details
Volatility	Extremely Dangerous	Details
Hype Condition	Over hyped	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Very High	Details
Economic Sensitivity	Very regressive towards the market	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Buy	Details
Financial Strenth (F Score)	Poor	Details
Financial Leverage	Inapplicable	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine CbdMD Stock

Researching CbdMD's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 21.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.4. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. cbdMD Inc recorded a loss per share of 10.29. The entity had not issued any dividends in recent years. The firm had 1:45 split on the 25th of April 2023.

To determine if CbdMD is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CbdMD's research are outlined below:

	cbdMD Inc had very high historical volatility over the last 90 days
	cbdMD Inc has some characteristics of a very speculative penny stock
	cbdMD Inc has a very high chance of going through financial distress in the upcoming years
	The company reported the previous year's revenue of 24.16 M. Net Loss for the year was (22.94 M) with profit before overhead, payroll, taxes, and interest of 22.34 M.
	cbdMD Inc currently holds about 10.55 M in cash with (4.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
	cbdMD Inc has a poor financial position based on the latest SEC disclosures
	Roughly 21.0% of the company outstanding shares are owned by insiders
	Latest headline from gurufocus.com: cbdMD Inc Q2 2024 Earnings Call Transcript Highlights Navigating Challenges with ...

CbdMD Quarterly Liabilities And Stockholders Equity

14.55 Billion

CbdMD uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in cbdMD Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CbdMD's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	12th of February 2024 Upcoming Quarterly Report	View
	31st of December 2023 Next Fiscal Quarter End	View

Earnings surprises can significantly impact CbdMD's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises CbdMD's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2023-08-10	2023-06-30	-0.04	-0.03	0.01	25
2023-05-15	2023-03-31	-0.04	-0.03	0.01	25
2023-02-13	2022-12-31	-0.04	-0.03	0.01	25
2022-02-10	2021-12-31	-0.04	-0.03	0.01	25
2021-12-17	2021-09-30	-0.04	-0.07	-0.03	75
2021-08-12	2021-06-30	-0.04	-0.01	0.03	75
2019-05-15	2019-03-31	-0.05	-0.09	-0.04	80
2024-05-15	2024-03-31	-0.75	-0.87	-0.12	16

CbdMD's market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CbdMD's market, we take the total number of its shares issued and multiply it by CbdMD's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

2.28 Million

CbdMD's profitablity analysis

CbdMD's profitability indicators refer to fundamental financial ratios that showcase CbdMD's ability to generate income relative to its revenue or operating costs. If, let's say, CbdMD is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, CbdMD's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of CbdMD's profitability requires more research than a typical breakdown of CbdMD's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.

	Last Reported	Projected for Next Year
Return On Tangible Assets	(2.03)	(2.13)
Return On Capital Employed	(2.24)	(2.13)
Return On Assets	(1.63)	(1.71)
Return On Equity	(2.29)	(2.40)

The company has Profit Margin (PM) of (0.85) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.2) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.2.

Determining CbdMD's profitability involves analyzing its financial statements and using various financial metrics to determine if CbdMD is a good buy. For example, gross profit margin measures CbdMD's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CbdMD's profitability and make more informed investment decisions.

The data published in CbdMD's official financial statements usually reflect CbdMD's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of cbdMD Inc. For example, before you start analyzing numbers published by CbdMD accountants, it's critical to develop an understanding of what CbdMD's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.

Please note, the presentation of CbdMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CbdMD's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in CbdMD's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of cbdMD Inc. Please utilize our Beneish M Score to check the likelihood of CbdMD's management manipulating its earnings.

Evaluate CbdMD's management efficiency

cbdMD Inc has return on total asset (ROA) of (0.1764) % which means that it has lost $0.1764 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1882) %, meaning that it created substantial loss on money invested by shareholders. CbdMD's management efficiency ratios could be used to measure how well CbdMD manages its routine affairs as well as how well it operates its assets and liabilities. As of May 17, 2024, Return On Tangible Assets is expected to decline to -2.13. The current year's Return On Capital Employed is expected to grow to -2.13. At present, CbdMD's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 167.5 K, whereas Non Current Assets Total are forecasted to decline to about 8.9 M.

	Last Reported	Projected for Next Year
Book Value Per Share	4.02	3.82
Net Current Asset Value	0.00	0.00
Tangible Asset Value	0.00	0.00
Tangible Book Value Per Share	2.59	2.72
Enterprise Value Over EBITDA	0.62	0.59
Price Book Value Ratio	0.27	0.25
Enterprise Value Multiple	0.62	0.59
Price Fair Value	0.27	0.25
Enterprise Value	4.6 M	4.3 M

The analysis of CbdMD's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze CbdMD's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of CbdMD Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.

Beta

1.982

Basic technical analysis of CbdMD Stock

As of the 17th of May 2024, CbdMD shows the Risk Adjusted Performance of 0.0419, semi deviation of 4.86, and Mean Deviation of 4.8. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of CbdMD, as well as the relationship between them. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for cbdMD Inc, which can be compared to its peers. Please confirm cbdMD Inc variance and the relationship between the treynor ratio and expected short fall to decide if cbdMD Inc is priced correctly, providing market reflects its regular price of 0.71548 per share. As cbdMD Inc is a penny stock we also strongly suggest to validate its total risk alpha numbers.

CbdMD's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CbdMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on CbdMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CbdMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Bradley Whitford over a month ago Disposition of tradable shares by Bradley Whitford of CbdMD subject to Rule 16b-3
		Sellers Bakari T. over a month ago Acquisition by Sellers Bakari T. of 2000 shares of CbdMD at 0.93 subject to Rule 16b-3
		Wiesehan John J Iii over a month ago Acquisition by Wiesehan John J Iii of 161550 shares of CbdMD at 2000000.0 subject to Rule 16b-3
		Sellers Bakari T over a year ago Acquisition by Sellers Bakari T of 5000 shares of CbdMD subject to Rule 16b-3

Understand CbdMD's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing CbdMD's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0419
	Market Risk Adjusted Performance	(0.24)
	Mean Deviation	4.8
	Semi Deviation	4.86
	Downside Deviation	5.5
	Coefficient Of Variation	1814.58
	Standard Deviation	6.61
	Variance	43.66
	Information Ratio	0.0386
	Jensen Alpha	0.4945
	Total Risk Alpha	(0.74)
	Sortino Ratio	0.0464
	Treynor Ratio	(0.25)
	Maximum Drawdown	37.68
	Value At Risk	(7.92)
	Potential Upside	12.22
	Downside Variance	30.22
	Semi Variance	23.65
	Expected Short fall	(6.46)
	Skewness	1.02
	Kurtosis	2.24

	Risk Adjusted Performance	0.0419
	Market Risk Adjusted Performance	(0.24)
	Mean Deviation	4.8
	Semi Deviation	4.86
	Downside Deviation	5.5
	Coefficient Of Variation	1814.58
	Standard Deviation	6.61
	Variance	43.66
	Information Ratio	0.0386
	Jensen Alpha	0.4945
	Total Risk Alpha	(0.74)
	Sortino Ratio	0.0464
	Treynor Ratio	(0.25)
	Maximum Drawdown	37.68
	Value At Risk	(7.92)
	Potential Upside	12.22
	Downside Variance	30.22
	Semi Variance	23.65
	Expected Short fall	(6.46)
	Skewness	1.02
	Kurtosis	2.24

Consider CbdMD's intraday indicators

CbdMD intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CbdMD stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Daily Balance Of Power	9.2 T
	Rate Of Daily Change	1.01
	Day Median Price	0.72
	Day Typical Price	0.72
	Price Action Indicator	(0)
	Period Momentum Indicator	0.0055
	Relative Strength Index	40.49

CbdMD time-series forecasting models is one of many CbdMD's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CbdMD's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

CbdMD Stock media impact

Far too much social signal, news, headlines, and media speculation about CbdMD that are available to investors today. That information is available publicly through CbdMD media outlets and privately through word of mouth or via CbdMD internal channels. However, regardless of the origin, that massive amount of CbdMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of CbdMD news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CbdMD relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CbdMD's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CbdMD alpha.

CbdMD Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards CbdMD can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Be your own money manager

Our tools can tell you how much better you can do entering a position in CbdMD without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

Piotroski F Score

Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

All Next

Launch Module

CbdMD Corporate Management

Elected by the shareholders, the CbdMD's board of directors comprises two types of representatives: CbdMD inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CbdMD. The board's role is to monitor CbdMD's management team and ensure that shareholders' interests are well served. CbdMD's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CbdMD's outside directors are responsible for providing unbiased perspectives on the board's policies.

Zeb Booker	Chief Officer	Profile
Raymond Coffman	CoFounder Chairman	Profile
Kevin MacDermott	President	Profile
John Weston	Director Relations	Profile
Shannon Charles	Chief Officer	Profile
Francisco Mangual	Senior Sales	Profile

How to buy CbdMD Stock?

Examine CbdMD's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research CbdMD's leadership team and their track record. Good management can help CbdMD navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact CbdMD's business and its evolving consumer preferences.
Compare CbdMD's performance and market position to its competitors. Analyze how CbdMD is positioned in terms of product offerings, innovation, and market share.
Check if CbdMD pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about CbdMD's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

Already Invested in cbdMD Inc?

The danger of trading cbdMD Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CbdMD is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CbdMD. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile cbdMD Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports: